1. Introduction {#sec1}
===============

Obesity is attaining epidemic proportions in Europe especially Greece \[[@B1], [@B2]\]. During the last decades obesity prevalence has increased significantly, especially among children and adolescents \[[@B1], [@B3]\]. This increase that began in the 1980s was attenuated over the last eight years \[[@B3]\]. Globally, an increase by 27.5% was observed in prevalence of overweight and obesity combined between 1980 and 2013 \[[@B3]\]. Nowadays, 71% of male and 51% of female adult Greeks are obese or overweight \[[@B3]\]. The prevalence of obesity was 28% and 26% among Greek men and women, respectively \[[@B4]\]. Obese patients are at increased risk of developing comorbidities, such as hypertension, coronary disease, chronic obstructive pulmonary disease, and diabetes \[[@B5]\]. In order to assess the presence of obesity the body mass index (BMI) is used and interpreted according to World Health Organization \[[@B6]\].

The relationship between obesity and mortality of critically ill patients remains unknown, since studies assessing the role of obesity in mortality among patients admitted to intensive care units (ICUs) show contradictory results \[[@B7], [@B8]\]. Due to comorbidities, several studies reported higher mortality rates among obese critically ill patients. On the contrary, recent studies found lower mortality in obese than in normal weight ICU patients \[[@B9], [@B10]\], a phenomenon referred to as the "obesity paradox" \[[@B11]\].

This paradox was also observed in subgroups of critically ill patients, such as patients with septic shock or those with peritonitis \[[@B12], [@B13]\]. The etiology for this paradox is not clear and can be due to selection bias in the study design or differences in patients\' characteristics \[[@B11]\].

The aims of this study were to describe the epidemiology of obesity among critically ill patients hospitalized in a Greek ICU, to assess its effect on ICU mortality and to investigate the correlation between sepsis and obesity.

2. Subjects and Methods {#sec2}
=======================

2.1. Patients and Data Collection {#sec2.1}
---------------------------------

This single-center retrospective study was performed in the general ICU of the University General Hospital of Patras (UGHP), Greece. UGHP is a tertiary hospital that accepts patients for the region of Western Greece, Peloponnese, and Ionian Islands and a population reaching one million people, whereas the ICU is separated in two compartments of ten and three beds, respectively. In the main compartment, two isolation and two semi-isolation beds are available. The medical records of all adult patients (≥18 years) that were admitted from November 2011 to February 2014 were reviewed until their discharge from the ICU. The study was approved from the Ethical Committee of the University Hospital of Patras (number 571). The need for informed consent was waived because of the retrospective and observational design of the study according to European legislation.

Patient data (epidemiologic data, comorbidities, colonization/infection, antimicrobial administration, and ICU procedures) were prospectively collected and recorded in the ICU computerized database (Criticus*™*, University of Patras, Greece). Severity scores of illness \[APACHE II (Acute Physiology and Chronic Health Evaluation II), SAPS (Simplified Acute Physiology Score II), and SOFA (Sequential Organ Failure Assessment)\] were calculated upon admission. Patients were included when they were aged 18 years or older. We excluded pregnant women and cardiac surgery patients. BMI was calculated for most of the patients upon ICU admission while nurses using a nonrigid measuring tape measured their height. According to the WHO criteria patients were categorized in five groups: underweight (\<18.5 kg/m^2^), normal weight (18.5--24.9 kg/m^2^), overweight (25--29.9 kg/m^2^), obese (30--39.9 kg/m^2^), and morbidly obese (≥40 kg/m^2^) \[[@B6]\]. Patients were categorized into the following groups according to the main reason for admission: trauma, spontaneous intracranial hemorrhage, sepsis, postoperative observation, respiratory insufficiency, and others (com*α*, epilepsy, intoxication, etc.). Sepsis and septic shock were defined according to the Third International Consensus Definitions for Sepsis and Septic Shock \[[@B14]\].

2.2. Statistical Analysis {#sec2.2}
-------------------------

Statistical analysis was performed with SPSS version 22.0 software package (IBM SPSS Statistics for Mac, Version 22.0, Armonk, NY, USA). For the statistical analyses patients were further categorized in two groups: obese patients (BMI ≥ 30 kg/m^2^) and nonobese patients (BMI \< 30 kg/m^2^). Categorical variables were analyzed by using the Fisher exact test or chi^2^ test while continuous variables were analyzed with Mann-Whitney *U* test or one-way ANOVA, as appropriate. Three different analyses were performed resulting from a predefined analysis plan. The first one was aimed at determining factors that differ among obese and nonobese patients. The second one was aimed at detecting predictors of ICU mortality of patients that were septic upon admission and the third one was aimed at determining the factors that differ among obese and nonobese septic patients. Backward stepwise multiple logistic regression analysis used all those variables from the univariate analysis with *P* \< 0.05. In order to identify factors that were highly correlated, collinearity diagnostics were performed. No factors contributing to multicollinearity were revealed (tolerance \> 0.2 and VIF \< 10 for all the factors analyzed). All statistic tests were 2-tailed and *P* \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

Of the 834 patients, 163 (19.5%) were obese and among them 25 (3.0%) were morbidly obese. [Table 1](#tab1){ref-type="table"} shows the univariate analysis of differences among obese and nonobese patients. Sixteen out of 38 factors were found to be statistically significant by univariate analysis (female gender, number of chronic diseases, diabetes mellitus, chronic obstructive disease, spontaneous intracranial hemorrhage, sepsis, ICU length of stay, ICU mortality, number of antibiotics administered, dialysis, enteral nutrition, KPC-Kp colonization, bloodstream infection and septic shock during ICU stay, KPC-Kp infection, and Candida infection during ICU stay). Multivariate analysis revealed that number of chronic diseases (*P* \< 0.001; OR 3.2; 95% CI 2.6--3.9), bloodstream infection during ICU stay (*P*  0.033; OR 2.0; 95% CI 1.1--3.7), and KPC-producing*Klebsiella pneumoniae* colonization during ICU stay (*P*  0.005; OR 2.2; 95% CI 1.3--3.7) were significantly associated with obesity, while nonobese patients suffer more frequently than obese patients from spontaneous intracranial hemorrhage (*P*  0.038; OR 0.22; 95% CI 0.05--0.92).

Total ICU mortality was 22.5% (188 patients). Obese patients were characterized by increased ICU mortality, as compared to nonobese ones (28.8% versus 21.0%; *P*  0.036). [Table 2](#tab2){ref-type="table"} shows the distribution of ICU patients according to the main reason for admission, BMI, and survival. Sepsis was the main condition of admission for which obese patients had statistically lower survival than normal weight subjects (76.3% versus 43.7%; *P*  0.001).

In order to determine the predictors of mortality among septic patients upon ICU admission (125 patients), a second analysis was conducted ([Table 3](#tab3){ref-type="table"}) by comparing survivors (58 patients) and nonsurvivors (67 patients). Univariate analysis revealed 12 statistically significant factors (number of chronic diseases, malignancy, cortisone use, obesity, SAPS II and SOFA score, parenteral nutrition, dialysis, meningitis, pneumonia, urinary-tract infection, and septic shock). Multivariate analysis revealed that SOFA score upon ICU admission (*P*  0.003; OR 1.3; 95% CI 1.1--1.5), obesity (*P*  0.014; OR 5.3; 95% CI 1.4--20.2), pneumonia (*P*  0.038; OR 3.5; 95% CI 1.1--11.3), and development of septic shock (*P*  0.015; OR 3.4; 95% CI 1.3--9.1) were all independently associated with mortality, while urinary-tract infection (*P*  0.010; OR 0.06; 95% CI 0.01--0.52) was associated with survival. Since obesity was an independent predictor of mortality among septic patients upon ICU admission, a further analysis was performed to assess the differences among obese and nonobese patients ([Table 4](#tab4){ref-type="table"}). Twelve out of 34 factors were found to be statistically significant by univariate analysis (ICU length of stay, mortality, cortisone use, number of antibiotics administered, mean antibiotic use per day, tracheostomy, number of invasive catheters, parenteral and enteral nutrition, dialysis, bloodstream infection, and KPC-Kp colonization during ICU stay). In multivariate analysis mortality (*P*  0.002; OR 4.9; 95% CI 1.8--13.2), bloodstream infection upon ICU admission (*P*  0.042; OR 3.1; 95% CI 1.0--9.0), and KPC-producing*K. pneumoniae* colonization during ICU stay (*P*  0.001; OR 2.1; 95% CI 1.3--3.2) were significantly associated with obese septic patients. According to Kaplan-Meier curves the 30-day survival probability is lower in obese septic patients compared to nonobese ones ([Figure 1](#fig1){ref-type="fig"}).

4. Discussion {#sec4}
=============

The percentages of overweight (39.9%) and obese (19.5%) patients admitted to the ICU were similar to that reported from previous prevalence studies in Greek population \[[@B3]--[@B5]\]. Obese patients suffered more often from chronic diseases as compared to nonobese patients, especially diabetes mellitus and chronic obstructive pulmonary disease, while male gender was more common among nonobese patients admitted to our ICU \[[@B2], [@B4]\]. An interesting finding of our study, reported for the first time, was that spontaneous intracranial (subarachnoid or intraparenchymal) hemorrhage was independently more common in nonobese patients. This contradicts the fact that obesity is a well-known risk factor for nontraumatic brain hemorrhage \[[@B15]\]. The low percentage of obese patients with brain hemorrhage in our study probably does not reflect the reality since, in the present study, only patients admitted to the ICU were included and not patients hospitalized in other hospital wards such as the neurosurgery department. Moreover, this is a retrospective study and further studies are needed in order to elucidate this association. The relatively high percentage of patients with intracranial hemorrhage admitted to the ICU can be explained by the fact that our hospital is the only tertiary hospital, with a neurosurgical department, in a region of one million people. All patients with intracranial hemorrhage diagnosed in other hospitals are transferred to our hospital.

In our study obese critically ill patients had lower ICU survival as compared to nonobese patients, in contrary to the results of previous studies that showed that obesity has a beneficial effect on ICU mortality \[[@B9], [@B10]\]. This phenomenon, which is known as "obesity paradox", has no apparent physiological explanation \[[@B11]\]. In a large cohort study Abhyankar et al. found that overweight and obese patients had higher survival rate both thirty days and one year after ICU admission \[[@B10]\]. In our study only obese patients admitted for sepsis presented higher mortality rate compared to nonobese patients, while no difference in outcome was observed in obese patients with other admission reasons. Like previous studies our study also showed that obesity did not influence mortality in patients admitted to the ICU for postoperative observation (nonobese 10.6% versus obese 4.2%, *P*  0.115) \[[@B16]\]. Moreover, the same observation was made for patients admitted after emergency surgery (25.2% versus 34.4%, *P*  0.376) \[[@B17]\].

Obesity has been identified as a risk factor for the development of nosocomial and community-acquired infections \[[@B18]\], but the relation between obesity and infection in critically ill patients is unclear \[[@B19]\]. In our study obesity was associated with infection upon admission and bacteremia during ICU stay. Dossett et al. have also shown that the rate of primary or catheter related bloodstream infection was significantly more common in obese as compared to nonobese patients \[[@B20]\]. Obesity has been seldom identified as a risk factor for colonization by multidrug resistant pathogens \[[@B21]\]. It is noteworthy in the present study that obese patients during ICU stay became more commonly colonized by KPC-producing*K. pneumoniae*, which resulted in higher incidence of infections provoked by the same pathogen. KPC-producing*K. pneumoniae* is prevalent in Greek ICUs causing infections associated with increased mortality \[[@B22]\]. Even though it can be argued that the high colonization rate among obese patients may be due to the prolonged length of stay of these patients (18.4 versus 8.8 days; *P*  0.004), we found that the length of stay until colonization by the aforementioned pathogen did not differ among obese and nonobese patients (9.6 versus 9.0 days; *P*  0.583), indicating that the length of stay plays no role in the colonization incidence. The higher rate of colonization and subsequent infection by KPC-producing*K. pneumoniae* may explain the increased antibiotic administration among critically ill obese patients ([Table 1](#tab1){ref-type="table"}), especially those used for the treatment of aforementioned infection, such as colistin, aminoglycosides, and tigecycline \[[@B23]\]. Obese patients received more commonly antifungal treatment, which can be explained by the increased length of stay of obese patients in the ICU and the higher rate of*Candida* infection. The latter is due to the fact that obesity predisposes to*Candida* species colonization which makes obese patients susceptible to candidemia \[[@B23]\].

Our study shows higher mortality rates in obese septic patients upon ICU admission as compared to nonobese ones. Even though obesity can be expected to be a predictor of mortality among septic patients, this topic remains a subject of considerable debate \[[@B12], [@B24]\]. A previous retrospective study of patients with septic shock found that obesity was associated with lower mortality, an association that could be influenced by the difference of age and comorbidities among groups \[[@B12]\]. Our study contradicts the results of the aforementioned study. The true effect of obesity on increased mortality, in our study, can be also supported by the fact that obese and nonobese septic patients had the same age and severity of illness upon ICU admission as it is depicted by APACHE II Score, SAPS II, and SOFA score while they also suffered from the same number of comorbidities and had similar rates of septic shock upon ICU admission. In the subgroup of patients admitted with pneumonia (66 patients), mortality was higher among obese patients (56.8% versus 83.3%; *P*  0.078). On the contrary a previous study showed a protective effect of obesity on mortality from community-acquired pneumonia \[[@B25]\]. This discrepancy of results can be explained by the fact that in our cohort study some cases of pneumonia were nosocomial and only severe cases of pneumonia warranting ICU admission were included.

A great percentage of patients (373/834) were admitted to the ICU for postoperative observation. There were similar rates of postoperative admission between obese and nonobese patients while the types of surgeries were the same. The operations included were abdominal, cardiovascular, neurosurgical, and orthopedic and no difference concerning the type of surgery was observed.

Our study has several limitations. Although we included all patients admitted to the ICU during a 28-month period, this is a single-center retrospective study. A second limitation of our study would be the fact that although the study included critically ill patients from a region of one million people, with high rates of multidrug resistant pathogens, our data cannot be extrapolated to patients worldwide. Finally, measurement of height or weight in recumbent patients is associated with errors arising from the presence of numerous attachments or volume depletion or overload.

5. Conclusion {#sec5}
=============

In our study prevalence of obesity among critically ill patients reflects prevalence of obesity of Greek population. Obesity was associated with higher incidence of infection and lower incidence of nontraumatic brain hemorrhage while, among patients with sepsis upon ICU admission, obesity was associated with higher mortality. The obesity paradox (lower mortality) was not observed in Greek critically ill patients probably due to the fact that obese ICU patients develop more commonly infections, especially by KPC-producing*K. pneumoniae*, which are associated with reduced survival. More studies are needed in order to evaluate the relationship between obesity and colonization or infection by multidrug resistant pathogens.
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###### 

Univariate and multivariate analysis of factors that differ among obese and nonobese critically ill patients. *P* depicts the univariate analysis results while (*∗*) denotes factors that differ in the multivariate analysis too (*P* \< 0.001 for number of chronic diseases, *P* = 0.033 for bloodstream infection during ICU stay, *P* 0.005 for KPC-producing *Klebsiella pneumoniae* colonization during ICU stay, and *P* 0.038 for spontaneous intracranial hemorrhage).

  Patient characteristics                               Nonobese patients (*n* = 671)   Obese patients (*n* = 163)   *P*
  ----------------------------------------------------- ------------------------------- ---------------------------- --------------
  *Demographics*                                                                                                      
   Age (years)                                          56.3 ± 19.8                     59.1 ± 14.8                  0.095
   Female gender                                        129 (32.2%)                     44 (43.6%)                   0.035
  *Chronic diseases (number)*                           0.7 ± 0.9                       1.0 ± 1.1                    0.001^*∗*^
   Diabetes mellitus                                    82 (12.2%)                      56 (34.4%)                   \<0.001
   Chronic obstructive pulmonary disease                63 (9.4%)                       39 (23.9%)                   \<0.001
   Chronic heart failure                                71 (10.6%)                      20 (12.3%)                   0.575
   Chronic renal failure requiring dialysis             38 (5.7%)                       11 (6.7%)                    0.580
   Malignancy (solid organ or heamatologic one)         162 (24.1%)                     33 (20.2%)                   0.305
   Cortisone use (within last month of ICU admission)   56 (8.3%)                       9 (5.5%)                     0.258
  *Reasons for admission*                                                                                             
   Spontaneous intracranial hemorrhage                  85 (12.7%)                      2 (1.2%)                     \<0.001^*∗*^
   Sepsis                                               87 (13.0%)                      38 (23.3%)                   0.001
   Respiratory insufficiency                            63 (9.4%)                       19 (11.7%)                   0.463
   Postoperative observation                            302 (45.0%)                     71 (43.6%)                   0.792
   Trauma                                               103 (15.4%)                     22 (13.5%)                   0.625
   Others^a^                                            31 (4.6%)                       11 (6.7%)                    0.316
  *Hospitalization data*                                                                                              
   Prior emergency surgery                              218 (32.5%)                     49 (30.1%)                   0.576
   Prior abdominal surgery                              194 (28.9%)                     49 (30.1%)                   0.774
   Prior hospitalization                                237 (35.3%)                     57 (35.0%)                   1.000
   APACHE II Score upon admission                       13.3 ± 7.5                      12.8 ± 7.1                   0.679
   SAPS II upon admission                               32.6 ± 13.8                     33.8 ± 13.1                  0.412
   SOFA score upon admission                            6.4 ± 3.8                       7.0 ± 3.5                    0.051
   ICU length of stay (days)                            8.8 ± 11.4                      18.4 ± 9.7                   0.004
   ICU mortality                                        141 (21.0%)                     47 (28.8%)                   0.036
  *ICU data*                                                                                                          
   Cortisone                                            225 (33.5%)                     64 (29.3%)                   0.170
  ** **Antibiotics administered (number)                2.4 ± 1.6                       2.9 ± 2.2                    0.036
   Mean antibiotic use per day                          1.9 ± 1.0                       2.1 ± 1.2                    0.088
   Tracheostomy                                         183 (27.3%)                     55 (33.7%)                   0.122
   Dialysis                                             27 (4.0%)                       16 (9.8%)                    0.005
   Parenteral nutrition                                 110 (16.4%)                     38 (23.3%)                   0.051
   Enteral nutrition                                    183 (27.3%)                     59 (36.2%)                   0.027
   Number of invasive catheters^b^                      0.8 ± 0.9                       1.0 ± 1.4                    0.253
  *Colonization/infection data*                                                                                       
   KPC-Kp colonization during ICU stay                  134 (20.0%)                     52 (31.9%)                   0.002^*∗*^
    Days until colonization                             9.0 ± 3.1                       9.6 ± 3.6                    0.583
   VRE colonization during ICU stay                     24 (3.6%)                       8 (4.9%)                     0.493
   Bloodstream infection during ICU stay                61 (9.1%)                       35 (21.5%)                   \<0.001^*∗*^
   Septic shock during ICU stay                         91 (13.6%)                      45 (27.6%)                   \<0.001
   KPC-Kp infection during ICU stay                     29 (4.3%)                       19 (11.7%)                   0.001
   Candida infection during ICU stay                    9 (1.3%)                        7 (4.3%)                     0.022

Data are number (%) of patients or mean ± SD.

ICU: intensive care unit; APACHE II: Acute Physiology and Chronic Health Evaluation II; SAPS: Simplified Acute Physiology Score II; SOFA: Sequential Organ Failure Assessment; KPC-Kp: KPC-producing *K. pneumoniae*; VRE: vancomycin-resistant *Enterococcus*.

^a^Coma, epilepsy, myocardial infarction, and intoxication.

^b^All patients after ICU admission were intubated and mechanically ventilated and were continuously monitored with a central venous catheter, an arterial catheter, and a urinary catheter. Number of catheters does not include the aforementioned ones.

###### 

Distribution of intensive care unit patients according to the main reason for admission, BMI, and survival. *P* denotes the difference in survival between obese and nonobese patients.

  Reasons for admission                      Nonobese (BMI ≤ 29.9)   Obese (BMI ≥ 30)   *P*                                                        
  ------------------------------------------ ----------------------- ------------------ ----------- ----------- ----------- ---------- ----------- ---------
  Spontaneous intracranial hemorrhage (87)   0 (0%)                  32 (25%)           53 (28%)    85 (27%)    2 (50%)     0 (0%)     2 (50%)     1.000
  Sepsis (125)                               0 (0%)                  40 (35%)           47 (51%)    87 (44%)    33 (85%)    5 (20%)    38 (76%)    \<0.001
  Respiratory insufficiency (82)             4 (50%)                 25 (20%)           34 (41%)    63 (33%)    14 (50%)    5 (0%)     19 (37%)    0.788
  Postoperative observation (373)            5 (0%)                  159 (9%)           138 (13%)   302 (11%)   60 (2%)     11 (18%)   71 (4%)     0.115
  Trauma (125)                               0 (0%)                  63 (17%)           40 (15%)    103 (17%)   20 (0%)     2 (100%)   22 (9%)     0.734
  Others^a^ (42)                             0 (0%)                  10 (40%)           21 (29%)    31 (32%)    9 (33%)     2 (100%)   11 (45%)    0.481
  All (834)                                  9 (22%)                 329 (17%)          333 (25%)   671 (21%)   138 (29%)   25 (28%)   163 (29%)   0.037

Data are number or patients that survived/deceased.

BMI (kg/m^2^).

^a^Coma, epilepsy, myocardial infarction, and intoxication.

###### 

Univariate and multivariate analysis ofpredictors of mortality among septic patients upon intensive care unit admission. *P* depicts the univariate analysis results while (*∗*) denotes factors that differ in the multivariate analysis too (*P* 0.003 for SOFA score upon admission, *P* 0.014 for obesity, *P* 0.038 for pneumonia, and *P* 0.015 for septic shock).

  Patient characteristics                               Survivors (*n* = 58)   Nonsurvivors (*n* = 67)   *P*
  ----------------------------------------------------- ---------------------- ------------------------- --------------
  *Demographics*                                                                                          
   Age (years)                                          59.0 ± 19.7            61.0 ± 17.1               0.603
   Male gender                                          28 (57.1%)             27 (57.4%)                1.000
  *Chronic diseases (number)*                           0.9 ± 1.0              1.6 ± 1.2                 \<0.001
   Diabetes mellitus                                    10 (17.2%)             17 (25.4%)                0.286
   Chronic obstructive pulmonary disease                12 (20.7%)             16 (23.9%)                0.830
   Chronic heart failure                                8 (13.8%)              9 (13.4%)                 1.000
   Chronic renal failure requiring dialysis             5 (8.6%)               4 (6.0%)                  0.732
   Malignancy (solid organ or heamatologic one)         2 (3.4%)               13 (19.4%)                0.006
   Cortisone use (within last month of ICU admission)   3 (5.2%)               13 (19.4%)                0.029
   Obesity                                              9 (15.5%)              29 (43.3%)                0.001^*∗*^
  *Hospitalization data*                                                                                  
   Prior emergency surgery                              14 (24.1%)             15 (22.4%)                0.835
   Prior abdominal surgery                              17 (29.3%)             17 (25.4%)                0.689
   Prior hospitalization                                36 (62.1%)             49 (73.1%)                0.249
   APACHE II Score upon admission                       16.9 ± 7.2             19.1 ± 8.4                0.323
   SAPS II upon admission                               39.8 ± 12.9            46.3 ± 12.8               0.007
   SOFA score upon admission                            8.1 ± 3.1              9.9 ± 4.2                 0.037^*∗*^
   ICU length of stay (days)                            14.5 ± 7.2             17.0 ± 17.4               0.216
  *ICU data*                                                                                              
   Cortisone                                            32 (55.2%)             48 (71.6%)                0.064
   Antibiotics administered (number)                    3.5 ± 1.8              3.9 ± 1.9                 0.149
   Mean antibiotic use per day                          2.8 ± 0.9              2.9 ± 0.9                 0.539
   Tracheostomy                                         25 (43.1%)             32 (47.8%)                0.719
   Number of invasive catheters^a^                      0.8 ± 1.4              1.1 ± 1.5                 0.072
   Parenteral nutrition                                 11 (19.0%)             24 (35.8%)                0.046
   Enteral nutrition                                    27 (46.6%)             35 (52.2%)                0.592
   Dialysis                                             3 (5.2%)               13 (19.4%)                0.029
  *Infection upon admission data*                                                                         
   Site of infection                                                                                      
    Meningitis                                          8 (13.8%)              2 (3.0%)                  0.044
    Pneumonia                                           22 (37.9%)             40 (59.7%)                0.020^*∗*^
    Intra-abdominal infection                           13 (22.4%)             14 (20.9%)                1.000
    Urinary-tract infection                             12 (20.7%)             3 (4.5%)                  0.011
    Skin and soft tissue infection                      3 (5.2%)               7 (10.4%)                 0.337
   Bloodstream infection                                6 (10.3%)              16 (23.9%)                0.060
   Septic shock                                         8 (13.8%)              47 (70.1%)                \<0.001^*∗*^
  *Colonization data*                                                                                     
   KPC-Kp colonization during ICU stay                  20 (34.5%)             21 (35.8%)                1.000
   VRE colonization during ICU stay                     5 (8.6%)               6 (9.0%)                  1.000

Data are number (%) of patients or mean ± SD.

ICU: intensive care unit; APACHE II: Acute Physiology and Chronic Health Evaluation II; SAPS: Simplified Acute Physiology Score II; SOFA: Sequential Organ Failure Assessment; KPC-Kp: KPC-producing *K. pneumoniae*; VRE: vancomycin-resistant *Enterococcus*.

^a^All patients after ICU admission were intubated and mechanically ventilated and were continuously monitored with a central venous catheter, an arterial catheter, and a urinary catheter. Number of catheters does not include the aforementioned catheters.

###### 

Univariate and multivariate analysis fordifference among obese and nonobese septic patients upon intensive care unit admission. *P* depicts the univariate analysis results while (*∗*) denotes factors that differ in the multivariate analysis too (*P* 0.002 for mortality, *P* 0.042 for bloodstream infection upon ICU admission, and *P* 0.001 for KPC-producing *K. pneumoniae* colonization during ICU stay).

  Patient characteristics                               Nonobese (*n* = 87)   Obese (*n* = 38)   *P*
  ----------------------------------------------------- --------------------- ------------------ --------------
  *Demographics*                                                                                  
   Age (years)                                          60.5 ± 19.5           59.2 ± 15.2        0.464
   Male gender                                          41 (62.1%)            14 (46.7%)         0.185
  *Chronic diseases (number)*                           0.9 ± 0.9             1.1 ± 1.1          0.242
   Diabetes mellitus                                    16 (18.2%)            11 (28.9%)         0.238
   Chronic obstructive pulmonary disease                17 (19.5%)            11 (28.9%)         0.253
   Chronic heart failure                                12 (13.8%)            5 (13.2%)          1.000
   Chronic renal failure requiring dialysis             8 (9.2%)              1 (2.6%)           0.274
   Malignancy (solid organ or heamatologic one)         9 (10.3%)             6 (15.8%)          0.385
   Cortisone use (within last month of ICU admission)   10 (11.5%)            6 (15.8%)          0.564
  *Hospitalization data*                                                                          
   Prior emergency surgery                              18 (20.7%)            11 (28.9%)         0.360
   Prior abdominal surgery                              21 (24.1%)            13 (34.2%)         0.278
   Prior hospitalization                                59 (67.8%)            26 (68.4%)         1.000
   APACHE II Score upon admission                       18.7 ± 7.8            16.2 ± 7.8         0.169
   SAPS II upon admission                               42.8 ± 13.3           44.3 ± 13.2        0.658
   SOFA score upon admission                            9.0 ± 3.9             9.2 ± 3.8          0.786
   ICU length of stay (days)                            11.9 ± 12.6           24.9 ± 26.4        \<0.001
   Mortality                                            38 (43.7%)            29 (76.3%)         0.001^*∗*^
  *ICU data*                                                                                      
   Cortisone                                            49 (56.3%)            31 (81.6%)         0.008
   Antibiotics administered (number)                    3.4 ± 1.5             4.9 ± 2.5          \<0.001
   Mean antibiotic use per day                          2.8 ± 0.9             3.1 ± 0.9          0.005
   Tracheostomy                                         31 (35.6%)            26 (68.4%)         0.001
   Number of invasive catheters^a^                      0.5 ± 0.8             1.9 ± 2.1          \<0.001
   Parenteral nutrition                                 19 (21.8%)            16 (42.1%)         0.030
   Enteral nutrition                                    37 (42.5%)            25 (65.8%)         0.020
   Dialysis                                             6 (6.9%)              10 (26.3%)         0.007
  *Colonization/infection data*                                                                   
   Site of infection                                                                              
    Meningitis                                          9 (10.3%)             1 (2.6%)           0.280
    Pneumonia                                           44 (50.6%)            18 (47.4%)         0.846
    Intra-abdominal infection                           15 (17.2%)            12 (31.6%)         0.098
    Urinary-tract infection                             13 (14.9%)            2 (5.3%)           0.148
    Skin and soft tissue infection                      6 (6.9%)              4 (10.5%)          0.490
   Bloodstream infection (primary or secondary)         10 (11.5%)            12 (31.6%)         0.010^*∗*^
   Septic shock                                         34 (39.1%)            21 (55.3%)         0.123
  *Colonization data*                                                                             
   KPC-Kp colonization during ICU stay                  21 (24.1%)            23 (60.5%)         \<0.001^*∗*^
   VRE colonization during ICU stay                     7 (8.0%)              4 (10.5%)          0.734

Data are number (%) of patients or mean ± SD.

ICU: intensive care unit; APACHE II: Acute Physiology and Chronic Health Evaluation II; SAPS: Simplified Acute Physiology Score II; SOFA: Sequential Organ Failure Assessment; KPC-Kp: KPC-producing *K. pneumoniae*; VRE: vancomycin-resistant *Enterococcus*.

^a^All patients after ICU admission were intubated and mechanically ventilated and were continuously monitored with a central venous catheter, an arterial catheter, and a urinary catheter. Number of catheters does not include the aforementioned catheters.

[^1]: Academic Editor: Flavia Prodam
